bf/NASDAQ:ADPT_icon.png

NASDAQ:ADPT

Adaptive Biotechnologies

  • Stock

USD

Last Close

15.56

06/11 21:44

Market Cap

515.79M

Beta: 1.18

Volume Today

2.01M

Avg: 909.46K

PE Ratio

−2.72

PFCF: −2.92

OverviewFinancialsAPI

    Description

    Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the con...Show More

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22018-09-302020-05-122022-05-042024-02-142024-11-14

    Revenue (Estimate*)

    20M40M60M80M100M120M140M2018-09-302020-05-122022-05-042024-02-142024-11-14

    *Estimate based on analyst consensus